Literature DB >> 12081107

A seroprevalence study of human herpesvirus type 8 (HHV8) in eastern and Central Africa and in the Mediterranean area.

D Serraino1, L Toma, M Andreoni, S Buttò, O Tchangmena, L Sarmati, P Monini, S Franceschi, B Ensoli, G Rezza.   

Abstract

Human herpes virus type 8 (HHV8) is the major determinant of Kaposi's sarcoma (KS), a neoplasm with wide geographic variations in incidence rates. To assess the prevalence of HHV8 infection among populations with differing rates of KS, we used sera from 1,402 persons (Central Africa: Cameroon, n = 293, age range: 5-40; eastern Africa: Uganda, n = 315, age range: 1-64: Mediterranean area: Egypt, n = 236, age range: 13-19: Italy, blood donors n = 134, age range: 20-67: Italy. HIV seroconverters n = 424, age range: 16-65). Serum samples were tested for antibodies to lytic and latent antigens of HHV8 using two immunofluorescence assays. HHV8 prevalence was evaluated according to geographic area, gender and age groups. Overall, the highest prevalence of HHV8 lytic antigens (47.5%) was recorded among children and adults in Africa. Approximately 40% of children and adolescents from Egypt and of Italian HIV-positive persons (39.9%) were HHV8 seropositive. In eastern and Central Africa and in Egypt, no differences emerged between males and females for both types of HHV8 antibodies. Conversely, Italian females were at lower HHV8 risk than their male counterparts. Moreover the prevalence of HHV8 infection tended to increase with age. This investigation partially confirms that HHV8 infection mirrors incidence rates of KS. The high prevalence of HHV8 infection in newborns, children and adolescents in Egypt, in eastern and in Central Africa strongly suggests the existence of transmission modes other than sexual.

Entities:  

Mesh:

Substances:

Year:  2001        PMID: 12081107     DOI: 10.1023/a:1015678312153

Source DB:  PubMed          Journal:  Eur J Epidemiol        ISSN: 0393-2990            Impact factor:   8.082


  43 in total

1.  Herpes-like sequences in HIV-infected and uninfected Kaposi's sarcoma patients.

Authors:  J A Ambroziak; D J Blackbourn; B G Herndier; R G Glogau; J H Gullett; A R McDonald; E T Lennette; J A Levy
Journal:  Science       Date:  1995-04-28       Impact factor: 47.728

2.  Human herpesvirus 8 seropositivity and risk of Kaposi's sarcoma and other acquired immunodeficiency syndrome-related diseases.

Authors:  G Rezza; M Andreoni; M Dorrucci; P Pezzotti; P Monini; R Zerboni; B Salassa; V Colangeli; L Sarmati; E Nicastri; M Barbanera; R Pristerà; F Aiuti; L Ortona; B Ensoli
Journal:  J Natl Cancer Inst       Date:  1999-09-01       Impact factor: 13.506

3.  Kaposi's sarcoma-associated herpesvirus-like DNA sequences in AIDS-related body-cavity-based lymphomas.

Authors:  E Cesarman; Y Chang; P S Moore; J W Said; D M Knowles
Journal:  N Engl J Med       Date:  1995-05-04       Impact factor: 91.245

4.  Increasing Kaposi's sarcoma-associated herpesvirus seroprevalence with age in a highly Kaposi's sarcoma endemic region, Zambia in 1985.

Authors:  S J Olsen; Y Chang; P S Moore; R J Biggar; M Melbye
Journal:  AIDS       Date:  1998-10-01       Impact factor: 4.177

5.  Antibodies to human herpesvirus type 8 in the general population and in Kaposi's sarcoma patients.

Authors:  E T Lennette; D J Blackbourn; J A Levy
Journal:  Lancet       Date:  1996-09-28       Impact factor: 79.321

6.  Human herpesvirus-like nucleic acid in various forms of Kaposi's sarcoma.

Authors:  Y Q Huang; J J Li; M H Kaplan; B Poiesz; E Katabira; W C Zhang; D Feiner; A E Friedman-Kien
Journal:  Lancet       Date:  1995-03-25       Impact factor: 79.321

7.  Kaposi's sarcoma-associated herpesvirus infection prior to onset of Kaposi's sarcoma.

Authors:  P S Moore; L A Kingsley; S D Holmberg; T Spira; P Gupta; D R Hoover; J P Parry; L J Conley; H W Jaffe; Y Chang
Journal:  AIDS       Date:  1996-02       Impact factor: 4.177

8.  A role for a new herpes virus (KSHV) in different forms of Kaposi's sarcoma.

Authors:  M Schalling; M Ekman; E E Kaaya; A Linde; P Biberfeld
Journal:  Nat Med       Date:  1995-07       Impact factor: 53.440

9.  Kaposi's sarcoma-associated herpesvirus DNA sequences in prostate tissue and human semen.

Authors:  P Monini; L de Lellis; M Fabris; F Rigolin; E Cassai
Journal:  N Engl J Med       Date:  1996-05-02       Impact factor: 91.245

10.  Kaposi's sarcoma-associated herpesvirus infects endothelial and spindle cells.

Authors:  C Boshoff; T F Schulz; M M Kennedy; A K Graham; C Fisher; A Thomas; J O McGee; R A Weiss; J J O'Leary
Journal:  Nat Med       Date:  1995-12       Impact factor: 53.440

View more
  15 in total

1.  Human herpesvirus 8 infection in children and adults in a population-based study in rural Uganda.

Authors:  Lisa M Butler; Willy A Were; Steven Balinandi; Robert Downing; Sheila Dollard; Torsten B Neilands; Sundeep Gupta; George W Rutherford; Jonathan Mermin
Journal:  J Infect Dis       Date:  2011-01-26       Impact factor: 5.226

2.  Population-based assessment of kaposi sarcoma-associated herpesvirus DNA in plasma among Ugandans.

Authors:  Fatma M Shebl; Benjamin Emmanuel; Lisa Bunts; Benon Biryahwaho; Christine Kiruthu; Meei-Li Huang; Ruth M Pfeiffer; Corey Casper; Sam M Mbulaiteye
Journal:  J Med Virol       Date:  2013-09       Impact factor: 2.327

3.  Seroprevalence and determinants of Kaposi sarcoma-associated human herpesvirus 8 in Indian HIV-infected males.

Authors:  Arshi Munawwar; Surendra K Sharma; Somesh Gupta; Sarman Singh
Journal:  AIDS Res Hum Retroviruses       Date:  2014-12       Impact factor: 2.205

4.  Localization of human herpesvirus type 8 in human sperms by in situ PCR.

Authors:  Omar Bagasra; Deepa Patel; Lisa Bobroski; Jamil A Abbasi; Alex U Bagasra; Hasna Baidouri; Twaina Harris; Albert El-Roeiy; Zsolt Lengvarszky; Homayoon Farzadegan; Charles Wood
Journal:  J Mol Histol       Date:  2006-01-10       Impact factor: 2.611

5.  Kaposi sarcoma-associated herpesvirus (KSHV) seroprevalence in population-based samples of African children: evidence for at least 2 patterns of KSHV transmission.

Authors:  Lisa M Butler; Grant Dorsey; Wolfgang Hladik; Philip J Rosenthal; Christian Brander; Torsten B Neilands; Georgina Mbisa; Denise Whitby; Photini Kiepiela; Anisa Mosam; Similo Mzolo; Sheila C Dollard; Jeffrey N Martin
Journal:  J Infect Dis       Date:  2009-08-01       Impact factor: 5.226

6.  Human herpesvirus 8 and pulmonary hypertension.

Authors:  Emanuele Nicastri; Carmine Dario Vizza; Fabrizio Carletti; Stefania Cicalini; Roberto Badagliacca; Roberto Poscia; Giuseppe Ippolito; Francesco Fedele; Nicola Petrosillo
Journal:  Emerg Infect Dis       Date:  2005-09       Impact factor: 6.883

7.  A population-based study of Kaposi Sarcoma-associated herpesvirus seropositivity in Uganda using principal components analysis.

Authors:  Joanne T Chang; Fatma M Shebl; Ruth M Pfeiffer; Benon Biryahwaho; Barry I Graubard; Sam M Mbulaiteye
Journal:  Infect Agent Cancer       Date:  2013-01-16       Impact factor: 2.965

8.  Seroprevalence and risk factors for human herpesvirus 8 infection, rural Egypt.

Authors:  Sam M Mbulaiteye; Ruth M Pfeiffer; Bryan Dolan; Victor C W Tsang; John Noh; Nabiel N H Mikhail; Mohamed Abdel-Hamid; Mohamed Hashem; Denise Whitby; G Thomas Strickland; James J Goedert
Journal:  Emerg Infect Dis       Date:  2008-04       Impact factor: 6.883

Review 9.  Review of the distribution of Kaposi's sarcoma-associated herpesvirus (KSHV) in Africa in relation to the incidence of Kaposi's sarcoma.

Authors:  M Dedicoat; R Newton
Journal:  Br J Cancer       Date:  2003-01-13       Impact factor: 7.640

10.  Human herpesvirus type 8 in tuberculosis patients with effusion.

Authors:  Shih-Ming Tsao; Chun-Liang Lai; Ming-Nan Lin; Jen-Pi Tsai; Cheng-Chuan Su
Journal:  BMC Infect Dis       Date:  2015-10-30       Impact factor: 3.090

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.